Anonymous ID: 26a9e3 Dec. 27, 2024, 10:50 a.m. No.22237789   🗄️.is 🔗kun   >>8095 >>8378

BOOM TIME… Doctors and nurses filed their brief to the 5th Circuit Court of Appeals regarding CEO Marc Boom of Houston Methodist requiring them to inject unlicensed drugs into their bodies in direct violation of the hospital's fed and state agreements.

 

https://x.com/GodsRiddles/status/1872693351650332904

 

Houston Methodist Hospital Faces Fifth Circuit Appeal Over Investigational Drug Mandate

https://www.thegatewaypundit.com/2024/12/houston-methodist-hospital-faces-fifth-circuit-appeal-investigational/

 

More than 100 healthcare professionals have taken their fight against Houston Methodist Hospital to the Fifth Circuit Court of Appeals, challenging the hospital’s 2021 COVID-19 shot mandate.

 

The lawsuit filed in Galveston federal court in 2023 alleges that Houston Methodist and CEO Marc Boom violated federal agreements by requiring employees to inject federally owned investigational drugs under threat of penalty.

 

The case has drawn the attention of medical ethics experts, including consultant Brian Ward. Ward spoke to The Gateway Pundit, saying that “the drugs under Houston Methodist’s mandate were wholly owned by the federal government and classified by the FDA as investigational new drugs.” For example, Ward noted that “Pfizer-BioNTech COVID-19 Vaccine is under Investigational New Drug (IND) application 19736 to this day and is only administered under laws regulating investigational drug treatments.”

 

Ward argued that Houston Methodist’s actions violated fundamental principles governing investigational medical treatments. He was adamant that “Houston Methodist could not even take possession of the drugs unless it explicitly promised the federal government that it only offers them under voluntary conditions.”

 

The case’s origins trace back to deeper historical roots in medical research oversight. In 1973, following Senate hearings led by Edward Kennedy that exposed the federal government’s medical research abuses, Congress passed the 1974 National Research Act.

 

According to Ward, this legislation led to the creation of “the Common Rule,” a set of federal regulations designed to protect individuals, such as the Plaintiffs in the case before the Fifth Circuit, from coming under threat of penalty to participate in “federally funded or authorized investigational drugs involuntarily.” This protection is guaranteed by the U.S. Congress, which requires Houston Methodist to “obtain Plaintiffs legally effective informed consent.”

 

“Legally effective informed consent” requires far more than “mere consent,” said Ward, explaining that consent must be obtained in advance of the product’s administration and that an offer to participate must be presented under a legally approved environment where the potential recipient is not under outside pressure to participate in its administration.

 

more: https://www.thegatewaypundit.com/2024/12/houston-methodist-hospital-faces-fifth-circuit-appeal-investigational/